市場調查報告書
商品編碼
1356558
膀胱癌診斷市場報告:至2030年的趨勢、預測與競爭分析Bladder Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
膀胱癌診斷的趨勢和預測
預計到2030年,全球膀胱癌診斷市場將達到 48 億美元,2024年至2030年年複合成長率為 7.8%。這個市場的主要促進因素是人們對膀胱相關疾病的認知不斷提高,老年人口不斷增加,以及對電腦斷層掃描和磁振造影等先進診斷技術的需求不斷增加。全球膀胱癌診斷市場的未來前景廣闊,醫院、診所和癌症中心市場存在商機。
膀胱癌診斷市場洞察
Lucintel 預測,有效的切片檢查技術,更增加使用切片檢查進行高級成像以及對經尿道膀胱腫瘤切除術的日益偏好將導致切片檢查有望實現最高成長。
由於膀胱癌入院人數迅速增加以及醫療專業人員的可用性,醫院可能仍然是最大的區隔。
由於擁有成熟的醫療基礎設施,領先的生技藥品公司以及主要參與者,預計北美將在預測期內實現最高的成長。
Bladder Cancer Diagnostic Trends and Forecast
The future of the global bladder cancer diagnostic market looks promising with opportunities in the hospital, clinic, and cancer center markets. The global bladder cancer diagnostic market is expected to reach an estimated $4.8 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are growing awareness of bladder related diseases, increasing number of geriatric popuation, and rising demand for advanced diagnostic technologies like computed tomography scan and magnetic resonance imaging.
A more than 150-page report is developed to help in your business decisions.
Bladder Cancer Diagnostic by Segment
The study includes a forecast for the global bladder cancer diagnostic by test type, cancer type, end use industry, technology, and region.
Bladder Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:
Bladder Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:
Bladder Cancer Diagnostic Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:
Bladder Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Bladder Cancer Diagnostic Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bladder cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bladder cancer diagnostic companies profiled in this report include-
Bladder Cancer Diagnostic Market Insights
Lucintel forecasts that biopsy is expected to witness highest growth over the forecast period due to its substantial use for effective biopsy technique and advanced imaging and rising preference for transurethral resection of bladder tumor approach.
Hospital will remain the largest segment due to surge in bladder cancer hospitalizations and substantial availability of healthcare experts in this setting.
North America is expected to witness highest growth over the forecast period due to exisitence of well-established healthcare infrastructure, availability of major biologics companies, and presence of key players in the region.
Features of the Global Bladder Cancer Diagnostic Market
Market Size Estimates: Bladder cancer diagnostic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Bladder cancer diagnostic market size by test type, cancer type, end use industry, and region. in terms of value ($B).
Regional Analysis: Bladder cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different test types, cancer typse, end use industries, and region.s for the bladder cancer diagnostic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bladder cancer diagnostic market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1. What is the bladder cancer diagnostic market size?
Answer: The global bladder cancer diagnostic market is expected to reach an estimated $4.8 billion by 2030.
Q.2. What is the growth forecast for bladder cancer diagnostic market?
Answer: The global bladder cancer diagnostic market is expected to grow with a CAGR of 7.8% from 2024 to 2030.
Q.3. What are the major drivers influencing the growth of the bladder cancer diagnostic market?
Answer: The major drivers for this market are growing awareness of bladder related diseases, increasing number of geriatric popuation, and rising demand for advanced diagnostic technologies like computed tomography scan and magnetic resonance imaging.
Q.4. What are the major segments for bladder cancer diagnostic market?
Answer: The future of the bladder cancer diagnostic market looks promising with opportunities in the hospital, clinic, and cancer center markets.
Q.5. Who are the key bladder cancer diagnostic market companies?
Answer: Some of the key bladder cancer diagnostic companies are as follows:
Q.6. Which bladder cancer diagnostic market segment will be the largest in future?
Answer: Lucintel forecasts that biopsy is expected to witness highest growth over the forecast period due to its substantial use for effective biopsy technique and advanced imaging and rising preference for transurethral resection of bladder tumor approach.
Q.7. In bladder cancer diagnostic market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to exisitence of well-established healthcare infrastructure, availability of major biologics companies, and presence of key players in the region.
Q.8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.